InductOs (rhBMP-2; dibotermin alfa) vs. autologous bone grafting for the treatment of nonunion of the docking site in tibial bone transport
Latest Information Update: 18 Jun 2024
At a glance
- Drugs Dibotermin alfa (Primary)
- Indications Non-union fracture
- Focus Therapeutic Use
- 16 Jun 2024 Status changed to completed.
- 15 Jul 2016 New trial record